Delivery Order SPE2DB20D2104-SPE2DB25F2019
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,756.97 to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 ml vial (10 ml) on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,892.26 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 31, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. The $10,299.41 contract has a performance period through February 6, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is placed against a...
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $17,265.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial (10ML), a typhoid vaccine product. This firm fixed-price contract, awarded on July 30, 2025, represents a non-competitive set-aside delivery order with an ultimate completion date of July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $3,903.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vial (10 ML) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- On July 23, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,035.56 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25F2019Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,585.44 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader indefinite delivery contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical supply requirements through open competition, with delivery orders spanning from nominal values to substantial orders exceeding $45,000. Through its DLA Troop Support Medical IDC, the company delivers specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 8/5/25 |